GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CKD Bio Corp (XKRX:063160) » Definitions » Cyclically Adjusted Price-to-FCF

CKD Bio (XKRX:063160) Cyclically Adjusted Price-to-FCF : (As of Jun. 05, 2024)


View and export this data going back to 2001. Start your Free Trial

What is CKD Bio Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


CKD Bio Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for CKD Bio's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CKD Bio Cyclically Adjusted Price-to-FCF Chart

CKD Bio Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 119.16 - - - -

CKD Bio Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of CKD Bio's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, CKD Bio's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CKD Bio's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CKD Bio's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where CKD Bio's Cyclically Adjusted Price-to-FCF falls into.



CKD Bio Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

CKD Bio's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, CKD Bio's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=259.276/118.8477*118.8477
=259.276

Current CPI (Mar. 2024) = 118.8477.

CKD Bio Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 1,443.595 99.353 1,726.852
201409 467.005 99.608 557.209
201412 427.401 99.098 512.580
201503 445.967 99.720 531.510
201506 337.980 100.050 401.481
201509 236.090 100.110 280.279
201512 -571.731 100.220 -677.998
201603 497.989 100.560 588.553
201606 876.996 100.790 1,034.120
201609 -726.827 101.460 -851.387
201612 232.506 101.560 272.084
201703 163.851 102.850 189.337
201706 193.067 102.610 223.619
201709 1,539.258 103.490 1,767.681
201712 104.198 102.990 120.242
201803 374.840 104.100 427.943
201806 403.279 104.130 460.278
201809 199.637 105.650 224.575
201812 -1,253.432 104.350 -1,427.576
201903 -2,162.249 104.490 -2,459.358
201906 618.998 104.880 701.435
201909 -2,333.242 105.200 -2,635.936
201912 -2,317.671 105.120 -2,620.337
202003 -3,145.810 105.540 -3,542.470
202006 -3,198.560 104.870 -3,624.883
202009 -3,304.934 106.200 -3,698.529
202012 -1,058.919 105.765 -1,189.898
202103 -2,172.903 107.357 -2,405.470
202106 -884.491 107.579 -977.143
202109 -1,446.211 108.759 -1,580.361
202112 -341.432 109.676 -369.983
202203 -191.211 111.806 -203.254
202206 112.735 114.083 117.444
202209 -826.894 114.831 -855.816
202212 -997.330 115.200 -1,028.908
202303 -1,075.768 116.550 -1,096.980
202306 -833.917 117.140 -846.075
202309 -1,791.231 119.111 -1,787.268
202312 419.424 118.848 419.424
202403 259.276 118.848 259.276

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


CKD Bio  (XKRX:063160) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


CKD Bio Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of CKD Bio's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


CKD Bio (XKRX:063160) Business Description

Industry
Traded in Other Exchanges
N/A
Address
368 Chungjeongno 3-ga, Seodaemun-gu, Seoul, KOR, 120-756
CKD Bio Corp is engaged in manufacturing and distribution of pharmaceutical materials and medicines. Its products portfolio include antibiotic, lactamase inhibitors, antituberculosis, antidiabetics, immunosuppressants, antihyperlipidemics, intermediates, and probiotics.

CKD Bio (XKRX:063160) Headlines

No Headlines